Dr. Marty Makary, professor of health policy at Johns Hopkins University, said on Thursday, Aug. 13, on the Fox News Rundown podcast that in terms of the development of the CCP virus vaccine, the United States is much more advanced than Russia.
Putin announced on Tuesday that Russia was the first country to register a safe vaccine for use against the CCP Virus and that one of his daughters had already been inoculated, Fox News reported.
But Makary clarified what the situation is regarding the United States: “It’s basically the equivalent of a Phase I trial approval when they say they’ve approved the medication,” he said. “It’s really based on very little data. I don’t think we can tolerate that in the United States in terms of safety and efficacy profile.”
Meanwhile, the United States is already in phase III clinical trials, putting the country far ahead of Russia, which is only in the equivalent of a phase I trial, he explained.
Makary believes a safe vaccine may not be available until late 2020 or early 2021.
The professor said that Tuesday’s announcement of Russia successfully creating a vaccine against the CCP Virus is a “publicity campaign” by Putin. “ Don’t jump on a plane and go to Russia to try to get this vaccine,” Makary warned.
Makary clarified that the standards in Russia for approving a vaccine are much lower than in the United States in terms of safety and efficacy profile.
In terms of infection rates, Makary attributed the reduction in positive case rates to herd immunity “in most of the country” and predicts “good news” for the coming weeks.